BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/23/2025 6:25:21 AM | Browse: 8 | Download: 35
 |
Received |
|
2025-08-05 00:10 |
|
Peer-Review Started |
|
2025-08-05 00:10 |
|
First Decision by Editorial Office Director |
|
2025-09-02 08:21 |
|
Return for Revision |
|
2025-09-02 08:21 |
|
Revised |
|
2025-09-15 04:18 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-17 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-17 09:30 |
|
Articles in Press |
|
2025-11-17 09:30 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-09 11:02 |
|
Publish the Manuscript Online |
|
2025-12-23 06:25 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Advances in prostate cancer treatment with moderate and ultra-hypofractionated radiotherapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ling-Ling Meng, Yu-Peng Di, Lin Ma and Bao-Lin Qu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bao-Lin Qu, MD, PhD, Professor, Department of Radiation Oncology, Senior Department of Oncology, The First Medical Center of PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, China. radiotherapy1018@126.com |
| Key Words |
Prostate cancer; Moderate; Ultra-hypofractionated; Radiation therapy; Treatment; Multidisciplinary collaboration |
| Core Tip |
Technological advances enabling precise targeting have driven continuous evolution in radiation therapy for prostate cancer. Moderate and ultra-hypofractionated regimens have been shown to be as effective as conventional therapy and offer patients greater convenience. However, optimizing treatment strategies requires overcoming challenges such as managing toxicity, defining the optimal dose/fractionation, integrating advanced diagnostics to enable personalized approaches and clarifying the role of radiation within multimodal management. Future progress hinges on refining novel techniques (e.g., FLASH and proton therapy), fostering multidisciplinary collaboration, and focusing on improving survival and quality of life outcomes for patients. |
| Publish Date |
2025-12-23 06:25 |
| Citation |
Meng LL, Di YP, Ma L, Qu BL. Advances in prostate cancer treatment with moderate and ultra-hypofractionated radiotherapy. World J Clin Oncol 2025; 16(12): 112735 |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i12/112735.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i12.112735 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
